1. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure 
Cherinne Arundel, MD, Phillip H. Lam, MD, Rahul Khosla, MD, Marc R. Blackman, MD, Gregg C. Fonarow, MD, Charity Morgan, PhD, Qing Zeng, PhD, Ross D. Fletcher, MD, Javed Butler, MD, MPH, MBA, Wen-Chih Wu, MD, Prakash Deedwania, MD, Thomas E. Love, PhD, Michel White, MD, Wilbert S. Aronow, MD, Stefan D. Anker, MD, PhD, Richard M. Allman, MD, Ali Ahmed, MD, MPH 
The American Journal of Medicine 
Volume 129, Issue 11, Pages (November 2016)
DOI: /j.amjmed
Copyright © Terms and Conditions

2. Figure 1
Love plot displaying absolute standardized differences comparing 34 baseline characteristics between heart failure patients with and without 30-day all-cause readmission, before and after propensity score matching. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © Terms and Conditions

3. Figure 2
Kaplan-Meier plot for all-cause mortality in a propensity-matched cohort of older heart failure patients with and without a 30-day all-cause readmission. CI = confidence interval; HR = hazard ratio.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © Terms and Conditions